期刊文献+

短期胰岛素泵强化治疗初诊2型糖尿病的临床观察 被引量:2

The Clinical Observation of Short-term Continuous Subcutaneous Insulin Infusion Treatment in Newly-diagnosed Type 2 Diabetic Patients
下载PDF
导出
摘要 目的:探讨短期胰岛素泵强化治疗对初诊的2型糖尿病患者血糖的控制情况及影响治疗成功的相关因素。方法:对18例初诊的2型糖尿病患者进行为期2周的胰岛素泵强化治疗。分析比较治疗前、后空腹及餐后2h血糖、糖化血红蛋白、甘油三酯、体重指数的变化,并对相关因素进行分析;随访长期的血糖控制情况。结果:2周的胰岛素泵治疗可使所有患者的血糖快速、稳定下降;13例合并降脂治疗者甘油三酯明显下降;治疗前后体重指数无变化;糖化血红蛋白也有明显下降;11例患者在用胰岛素泵治疗后采用饮食控制及运动锻炼,随访超过6个月仍保持血糖正常。年龄较轻、强化期间胰岛素用量小者,则治疗成功率较高。结论:时初发2型糖尿病患者,短期胰岛素泵强化治疗可使部分患者仅通过饮食控制及运动锻炼即能获得良好的血糖控制。 Objective:To investigate the clinical outcome of short-term intensive insulin treatment on long-term glycemic control in newly diagnosed type 2 diabetes patients and discuss the affecting factors. Methods: 18 newly diagnosed type 2 diabetes patients were treated with CSII for 2 weeks. FBG, PG2h, HbAlc,TG,BMI were assessed before and after the insulin treatment. After the treatment,all patients were followed up for their glycemic control level. Results: The optimal glycemic control in all patients were acquired rapidly and stably by CSII. TG level decreased significantly in thirteen patients combined with lipidcontrol agents. BMI had no significant changes before and after CSII. The significant decrease of HbAlc was observed. The gly cemic level of Eleven patients maintained normal on diet and movement more than six months. And find the younger and less of the insulin dosage during the CSII, the higher success rate is. Conclusion:Short-term intensive insulin therapy can induce longterm glycernic control in newly diagnosed type 2 diabetes patients.
出处 《中国临床医学》 北大核心 2006年第6期970-972,共3页 Chinese Journal of Clinical Medicine
基金 上海市青浦区科学技术委员会科研资金资助项目(编号200447)
关键词 胰岛素泵 短期胰岛素强化治疗 初诊2型糖尿病 Insulin pump Short-term continous subcutaneous insulin infusion treatment Newly diagnosed type 2 diabetic patients
  • 引文网络
  • 相关文献

参考文献4

二级参考文献16

  • 1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.

共引文献1316

同被引文献8

引证文献2

二级引证文献4

;
使用帮助 返回顶部